ASLAN Pharmaceuticals today provides an update on timelines for Clinical Trial of Varlitinib in Biliary Tract Cancer in China
For more information, please refer to the English or Chinese press release.
The Website may contain links to or from other websites, over which ASLAN has no control. These linked sites are for your convenience only and you access them at your own risk.
ASLAN is not responsible for the content of the linked sites. ASLAN does not in any way endorse the linked sites.
Read about our latest product developments and partnerships, industry advances and events.